Satsuma Pharmaceuticals, Inc.   Report issue

For profit Phase 3
Founded: San Francisco CA United States (2016)

Organization Overview

First Clinical Trial
2018
NCT03874832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Satsuma Pharmaceuticals, Inc.